BAXALTA INC.

BAXALTA INC. supports the value we place on spinoffs. The company makes vaccines and drugs. Until July 1, 2015, it was a subsidiary of Baxter International (New York symbol BAX). That’s when Baxter set it up as a separate firm. Investors received one Baxalta share… Read More

Another spinoff success

BAXALTA INC. supports the value we place on spinoffs. The company makes vaccines and drugs. Until July 1, 2015, it was a subsidiary of Baxter International (New York symbol BAX). That’s when Baxter set it up as a separate firm. Investors received one Baxalta share… Read More

BAXTER INTERNATIONAL INC. $39

BAXTER INTERNATIONAL INC. $39(New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 547.0 million; Market cap: $21.3 billion; Price-to-sales ratio: 2.1; Dividend yield: 1.2%; TSINetwork Rating: Average; www.baxter.com) earned $755 million, or $1.38 a share, in 2015 before unusual items. That’s… Read More

Spinoff created 2 quality medical stocks

On July 1, 2015, Baxter International handed out 80.5% the shares in its Baxalta subsidiary to its investors on a one-for-one basis. Baxalta makes vaccines and drugs in three main areas: hematology (blood diseases), immunology (immune system) and oncology (cancer).

Baxter now focuses on medical… Read More